Lena Bornhöft

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

BMC public health

Therapeutic advances in musculoskeletal disease

Scandinavian journal of primary health care

BMC musculoskeletal disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Lena Bornhöft, Daniel Arvidsson, Anna Bergenheim, Mats Börjesson, Jonatan Fridolfsson, Margareta Hellgren, Lena Nordeman, Maria Eh Larsson
Development and feasibility of a function-based preventive intervention for lifestyle-related disorders. BMC public health 24 (1) (2024)
Lena Bornhöft, Susanne Bernhardsson, Lena Nordeman, Anna Grimby-Ekman, Maria Dottori, Maria E H Larsson
Monitoring handgrip strength to motivate lifestyle choices for patients with diabetes type 2 - a pragmatic randomised controlled trial. Scandinavian journal of primary health care (2024)
Lena Bornhöft, Daniel Arvidsson, Anna Bergenheim, Mats Börjesson, Jonatan Fridolfsson, Margareta Hellgren, Lena Nordeman, Maria Eh Larsson
Development and feasibility of a function-based preventive intervention for lifestyle-related disorders. BMC public health 24 (1) (2024)
Lena Bornhöft, Daniel Arvidsson, Anna Bergenheim, Mats Börjesson, Jonatan Fridolfsson, Margareta Hellgren, Lena Nordeman, Maria Eh Larsson
Development and feasibility of a function-based preventive intervention for lifestyle-related disorders. BMC public health 24 (1) (2024)
Lena Bornhöft, Jörgen Thorn, Mikael Svensson, Lena Nordeman, Robert Eggertsen, Maria E H Larsson
More cost-effective management of patients with musculoskeletal disorders in primary care after direct triaging to physiotherapists for initial assessment compared to initial general practitioner assessment. BMC musculoskeletal disorders 20 (1) (2019)
Lena Bornhöft, Maria Eh Larsson, Lena Nordeman, Robert Eggertsen, Jörgen Thorn
Health effects of direct triaging to physiotherapists in primary care for patients with musculoskeletal disorders: a pragmatic randomized controlled trial. Therapeutic advances in musculoskeletal disease 11 (2019)